Estimated antiretroviral therapy coverage among people living with HIV in Saudi Arabia
Saudi Arabia: Estimated antiretroviral therapy coverage among people living with HIV was 97.0% in 2025. ▲ Rising
Estimated antiretroviral therapy coverage among people living with HIV in Saudi Arabia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among people living with hiv in Saudi Arabia is 97.0%, measured in 2025. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 5.4% on the previous year and up 98.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Saudi Arabia peaked at 97.0% in 2025 and was at its lowest, 31.0%, in 2000.
Saudi Arabia ranks 2nd of 143 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 26 years of available data.
Estimated antiretroviral therapy coverage among people living with HIV in Saudi Arabia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 31.0% | — |
| 2001 | 32.0% | +3.2% |
| 2002 | 34.0% | +6.2% |
| 2003 | 35.0% | +2.9% |
| 2004 | 36.0% | +2.9% |
| 2005 | 37.0% | +2.8% |
| 2006 | 38.0% | +2.7% |
| 2007 | 39.0% | +2.6% |
| 2008 | 40.0% | +2.6% |
| 2009 | 40.0% | +0.0% |
| 2010 | 39.0% | -2.5% |
| 2011 | 38.0% | -2.6% |
| 2012 | 37.0% | -2.6% |
| 2013 | 38.0% | +2.7% |
| 2014 | 42.0% | +10.5% |
| 2015 | 49.0% | +16.7% |
| 2016 | 58.0% | +18.4% |
| 2017 | 61.0% | +5.2% |
| 2018 | 67.0% | +9.8% |
| 2019 | 74.0% | +10.4% |
| 2020 | 77.0% | +4.1% |
| 2021 | 79.0% | +2.6% |
| 2022 | 84.0% | +6.3% |
| 2023 | 88.0% | +4.8% |
| 2024 | 92.0% | +4.5% |
| 2025 | 97.0% | +5.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 36.2% | 31.0% | 40.0% | 10 |
| 2010s | 50.3% | 37.0% | 74.0% | 10 |
| 2020s | 86.2% | 77.0% | 97.0% | 6 |
Countries ranked near Saudi Arabia
More health data for Saudi Arabia
- Un projection of annual infant deaths, annual growth rate -0.8373 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3736 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 483.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 829 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate 5.31 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0384 units per person (2025)
- Population ages 00-04, male, annual growth rate 5.38 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Saudi Arabia?
- Estimated antiretroviral therapy coverage among people living with hiv in Saudi Arabia was 97.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Saudi Arabia?
- The highest recorded value was 97.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Saudi Arabia?
- The lowest recorded value was 31.0% in 2000.
- How does Saudi Arabia rank for estimated antiretroviral therapy coverage among people living with hiv?
- Saudi Arabia ranks 2nd out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Saudi Arabia?
- Over the last ten years it is up 98.0%. The long-run trend across the full record is rising.
- Where does this Saudi Arabia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).